# CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)

> **NCT00621621** · PHASE4 · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 105 (actual)

## Conditions studied

- Tachycardia, Atrioventricular Nodal Reentry

## Interventions

- **DEVICE:** Freezor® Cardiac Cryoablation Catheter CryoConsole System

## Key facts

- **NCT ID:** NCT00621621
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00621621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00621621, "CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00621621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*